FDA.reportPublic FDA data

azithromycin 2 GM per 60 ML Extended Release Suspension

RxCUI
577378
RxNorm name
azithromycin 2 GM per 60 ML Extended Release Suspension
Display name
azithromycin 2 GM per 60 ML Extended Release Suspension
Full name
azithromycin 2 GM per 60 ML Extended Release Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c61229e8-75cb-4776-9883-c5630bc38a32azithromycin 2 GM in 60 mL Extended Release Oral Suspension [PSN] · azithromycin 33.3 MG/ML Extended Release Suspension [SCD] · azithromycin 2 GM per 60 ML Extended Release Suspension [SY]31These highlights do not include all the information needed to use ZMAX safely and effectively. See full prescribing information for ZMAX. ZMAX (azithromycin) powder, for suspension for oral use Initial U.S. Approval: 199120110126